How to Buy Organogenesis Holdings Stock
Organogenesis Holdings Inc
Organogenesis Holdings Inc. , a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States.
Organogenesis Holdings stock last closed at $4.91, up 0.61% from the previous day, and has increased 108.94% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 1.67 percentage points. Organogenesis Holdings stock is currently +122.17% from its 52-week low of $2.21, and -26.83% from its 52-week high of $6.71.
At the moment, there are 126.83M shares of ORGO outstanding. The market cap of ORGO is $622.73M. In the last 24 hours, 1.66M ORGO shares were traded.
How to Buy Organogenesis Holdings Stock
Wondering how to invest in Organogenesis Holdings stock? Here's how.
- Figure out where to buy Organogenesis Holdings stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you decide where to buy Organogenesis Holdings stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Put funds into your brokerage account: Choose your method of payment and add your information.
- Analyze Organogenesis Holdings stock: The Organogenesis Holdings ticker symbol is ORGO. Is Organogenesis Holdings stock a good investment? Should you buy shares of ORGO? How do ORGO's underlying business fundamentals look? Do top analysts think Organogenesis Holdings is a good buy? Why has ORGO's stock price moved recently? (Hint: Our stock market research tools can help you evaluate if ORGO is a good stock to buy).
- Make your ORGO purchase: Decide if you will purchase ORGO shares at the current market price or use a limit order to purchase ORGO shares at a specific price.
- Watch your investment in ORGO: Create a watchlist to track your position in Organogenesis Holdings shares.
Step 1: Figure out where to buy Organogenesis Holdings stock
You need a brokerage account in order to access the NASDAQ market and buy ORGO shares.
Our recommended brokerage: eToro
Based on our research, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global financial markets: From Tech to Utilities, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've chosen your brokerage, you'll need to fill out some personal details so you can buy ORGO stock today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to start your new brokerage account.
- Send your details by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you have created your account on the best stock investing app, your next step is to transfer the money for your investment:
Check out the tutorial below for more details transferring funds into your new investment account.
Step 4: Analyze Organogenesis Holdings stock
Once you have chosen the best place to buy Organogenesis Holdings stock, it's absolutely critical to analyze their stock before you invest, so you actually understand the risk and opportunity.
Organogenesis Holdings shares quick numbers
Organogenesis Holdings Due Diligence Checks
WallStreetZen was created to help average investors perform more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on ORGO's stock page.
How is ORGO stock valued?
Analysts use many financial metrics, analyses, models, and charts to gauge ORGO's intrinsic value.
Using relative valuations methods:
- ORGO may be overvalued based on its P/B ratio of 2.37x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2.09x
You can do more valuation analysis on ORGO's stock here.
ORGO Financial Health
Passed Health Checks:
- There are more short-term assets than short-term liabilities on the ORGO balance sheet.
- Total ORGO debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the ORGO balance sheet.
- ORGO's operating cash flow of $14.21M allows it to safely service it's debt of $43.31M.
Failed Health Checks:
- ORGO earnings of -$1.26M is not enough to cover its interest payments.
- ORGO has a relatively high debt to equity ratio of 0.43.
- ORGO profit margin has gone down from 1.1% to -0.2% in the past year.
Is it a good time to buy Organogenesis Holdings stock, according to analysts?
Out of 1 Equities analysts who give ratings on ORGO, the consensus analyst rating on Organogenesis Holdings is a Hold
Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are saying on the Organogenesis Holdings stock forecast page.
ORGO Momentum
ORGO Growth Metrics
Last year, ORGO revenue was $482.04M. During the last 5 year, ORGO's revenue has increased by 13.06% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 7.88%.
Dig into ORGO's earnings and revenue performance here.
Latest Insiders Trades at ORGO
In the last 12 months, executives and large shareholders at ORGO have sold more shares than they have bought.
Robert Cavorsi, Vice President Strategy of ORGO, was the latest ORGO insider to sell. They sold $1,083.60 worth of ORGO shares on Mar 9, 2025.
Research more about who owns ORGO stock here.
Can I rely on ORGO as an income stream?
No, Organogenesis Holdings doesn't provide an income stream by paying out dividends.
What do other traders have to say about ORGO?
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your ORGO purchase
You have two main options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are mostly fine for most investors. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a specific price, place a limit order.
Hit the Open Trade button and eToro will place the order.
If you want additional assistance buying stocks on eToro, click the helpful video below:
Step 6: Watch your investment in ORGO
Now that you own some ORGO shares, you'll want to stay up-to-date on your investment.
Create a watchlist to track the most important metrics related to your ORGO stock.
ORGO Feed
How to Buy Stock in Organogenesis Holdings
To summarize, here are the 6 steps for buying Organogenesis Holdings stock:
- Figure out where to buy Organogenesis Holdings stock
- Open a brokerage account
- Put funds into your brokerage account
- Analyze Organogenesis Holdings stock
- Make your ORGO purchase
- Watch your investment in ORGO
If you need a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep track of your new investment in Organogenesis Holdings, click the button below.
More Content You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.